Medical and Health Sciences | Article | Published 2021

Prevention Fundamentals of Acute Coronary Syndromes in Uzbekistan

Authors:
Publisher: Global Journal of Medical Research
Keywords: Prevention Fundamentals of Acute Coronary Syndromes in Uzbekistan

Abstract

Background: Cardiovascular disease (CVD) is the leading cause of death worldwide. An estimated 17.9 million people died from cardiovascular disease only in 2019, accounting for 32% of all deaths worldwide. Of these deaths, 85% were caused by heart attack and stroke. More than three quarters of deaths from cardiovascular disease occur in low- and middle-income countries.

References

  1. Aronov D.M. “Treatment of atherosclerosis and
  2. prevention”. - M.: Triada X, 2000. [Аronov D. M.
  3. Lechenie ateroskleroza i profilaktika. — M.: Triada X,
  4. 2000.]
  5. . Bokarev I.N., Aksenova M.B., Khlevchuk T.V. Acute
  6. coronary syndrome and its treatment // Textbook. -
  7. Moscow. - 2009 .-- p. 170 [Bokarev I.N., Аksenova
  8. M.B., Xlevchuk T.V. Ostry koronarniy sindrom i yego
  9. lechenie // Uchebnoe posobie. – Moskva. – 2009. –
  10. s.170]
  11. . Vertkin A.L. Emergency. A guide for doctors. -
  12. Moscow. – 2007 [Skoraya meditsinskaya pomosh.
  13. Rukovodstvo dlya vrachey. – Moskva. - 2007]
  14. . Diagnostics and treatment of patients with acute
  15. myocardial infarction with ST-segment elevation of
  16. the electrocardiogram. // Russian recommenddations. Committee of Experts of the All-Russian
  17. Scientific Society of Cardiology. - M. - 2007. - 66s
  18. [Diagnostika i lechenie bolnix ostrim infarktom
  19. miokarda s podemom segmenta ST
  20. elektrokardiogrammi. // Rossiyskiy rekomendatsii.
  21. Komitet ekspertov Vserossiyskogo nauchnogo
  22. obshestva kardiologov. – M. – 2007. – 66s]
  23. Lange R., Hillis D. “Reperfusion therapy in acute
  24. myocardial infarction” // International Med. Journal. -
  25. 2002. -, No. 6. - S. 28-33. [Lange R., Xillis D.
  26. Reperfuzionnaya terapiya pri ostrom infarkte
  27. miokarda // Mejdunarodniy Med. Jurn. — 2002. - ,
  28. № 6. - S. 28-33.]
  29. I.I. Staroverov, “Myocardial infarction: new
  30. perspectives of fibrinolytic therapy” // Doctor. RU. -
  31. 2004. - No. 4. - S.52-53. [Staroverov I.I. Infarkt
  32. miokarda: novie perspektivi fibrinoliticheskoy terapii
  33. //Doktor. Ru. – 2004. - №4. – S.52-53.]
  34. I.S. Yavelov, “The use of beta-blockers for
  35. cardiovascular diseases: current
  36. recommendations.” // Cons Med. - 2005; 7; 945-56.
  37. [Yavelov I.S. Primenenie beta-adrenoblokatorov pri
  38. serdechno-sosudistix zabolevaniyax: sovremennie
  39. rekomendatsii. //Cons Med. – 2005; 7; 945-56.]. 2007 Focused Update of the ACC/AHA 2004
  40. Guidelines for the Management of Patients With STElevation Myocardial Infarction. American College of
  41. Cardiology/American Heart Association Task Force
  42. on Practice Guidelines Developed in Collaboration
  43. With the Canadian Cardiovascular Society Endorsed
  44. by the American Academy of Family Physicians
  45. 2007 Writing Group to Review New Evidence and
  46. Update the ACC/AHA 2004 Guidelines for the
  47. Management of Patients With ST-Elevation
  48. Myocardial Infarction, Writing on Behalf of the 2004
  49. Writing Committee J Am Coll Cardiol, 2008; 51:210-
  50. 247.
  51. . ACC/AHA 2002 Guidelines Update for the
  52. Management of Patients with Chronic Stable Angina
  53. - summary article. A Report of ACC/AHA Task Force
  54. on Practice Guidelines // Circulation. –
  55. 2003.107:149-158.
  56. . ACC/AHA 2007 Guidelines for the Management of
  57. Patients With Unstable Angina/Non–ST-Elevation
  58. Myocardial Infarction. A Report of the American
  59. College of Cardiology/American Heart Association
  60. Task Force on Practice Guidelines (Writing
  61. Committee to Revise the 2002 Guidelines for the
  62. Management of Patients With Unstable
  63. Angina/Non–ST-Elevation Myocardial Infarction). //J
  64. Am Coll Cardiol. – 2007; 50: 1-157.
  65. . ACC/AHA 2007 Guidelines for the management of
  66. patients with unstable angina/non—st-elevation
  67. myocardial infarction. A report of the American
  68. College of Cardiology /American Heart Association
  69. Task force on practice guidelines (writing committee
  70. to revise the 2002 guidelines for the management of
  71. patients with unstable angina/non—st-elevation
  72. 31Year 2021 Global Journal of Medical Research Volume XXI Issue VII Version I ( ) F
  73. © 2021 Global Journals
  74. Prevention Fundamentals of Acute Coronary Syndromes in Uzbekistan
  75. myocardial infarction). //Circulation. – 2007; 116:
  76. el48-e304.
  77. . ACC/AHA Guidelines Update for the Management
  78. of Patients with Unstable Angina and non-ST
  79. segment Elevation Myocardial Infarction: a Report of
  80. the American College of Cardiology/ American Heart
  81. Association Task Forse on Practice Guidelines
  82. (Committee on the Management of Patients With
  83. Unstable Angina) // Circulation. 2002; 106: 1893-
  84. 1900.
  85. . АСС/АНА Guidelines for the Management of
  86. Patients With Acute Myocardial Infarction. 1999
  87. Uptate. A Report of the American College of
  88. Cardiology/American Heart Association Task Force
  89. on Practice Guidelines (Committee on Management
  90. of Acute Myocardial Infarction). Web version.
  91. . CAPRIE Streering Committee: A randomized,
  92. blinded trial of clopidogrel versus aspirin in patients
  93. at risk of ischemic events // Lancet. – 1996. 348:
  94. 1329.
  95. . CAPTURE investigators: Randomised placebocontrolled trial of abciximab before and during
  96. coronary intervention in refractory unstable angina //
  97. //Lancet. – 1997. 349: 1429.
  98. . Folland ED, Hartigan PM, Parisi AF. Percutaneous
  99. transluminal coronary angioplasty (PTCA) compared
  100. to medical therapy for stable angina pectoris:
  101. outcomes for patients with double vessel compared
  102. to single vessel coronary artery disease in
  103. randomized VA cooperative study. //JACC. – 1997;
  104. 29: 1505-11.
  105. . Krolewski A.S., Warram J.H., Valsania P. Evolving
  106. natural history of coronary artery disease in diabetes
  107. mellitus. //AmMed. – 1991; 90[Suppl 2A]: 56S-61S.
  108. . Lansky A.J., Hochman J.S., Ward P.A.
  109. Percutaneous coronary intervention and adjunctive
  110. pharmacotherapy in women: a statement for
  111. healthcare professionals from the American Heart
  112. Association. //Circulation. – 2005; 111:940 –53.
  113. . Manson J.E. Body weight and mortality among
  114. women. //N Engl J Med – 1995; 333:677-685.
  115. . Matriniuk A.L.C, Lee C.M.Y, Lam T.H, Huxley R., Suh
  116. I., Jamrozik K., Gu D.F., Woodward M. For the AsiaPacific Cohort Studies Collaboration. The fraction of
  117. ischaemic heart disease and stroke attributable to
  118. smoking in the WHO Western Pacific and SouthEast Asian regions. //Tob Control. – 2006; 15:
  119. 181–188.
  120. . Mokdad A.H., Ford E.S., Bowman B.A., Dietz W.H.,
  121. Vinicor F., Bales V.S., Marks J.S. Prevalence of
  122. obesity, diabetes, and obesity-related health risk
  123. factors, 2001. //JAMA Jan 1; 2003 289 (1): 76–9.
  124. . Morrison L.J., Verbeek P.R., McDonald A.C.,
  125. Sawadsky B.V., Cook D.J. Mortality and prehospital
  126. thrombolysis for acute myocardial infarction: a
  127. meta-analysis. //JAMA. – 2000; 283: 2686–2692.
  128. . Olsson A.G., Schwartz G.G. Early initiation of
  129. treatment with statins in acute coronary syndromes.
  130. //Ann Med. – 2002; 34: 1: 37— 41
Loading...
0

Views

0

Reads

0

Comments

0

Reviews

0

Liked

0

Shared

0

Bibliography

0

Citations

Like and share on

Cite this publication

Copy text below and use in your article